Ikarian Capital LLC 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-08 9:59 pm Purchase |
2020-09-18 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
Ikarian Capital LLC | 31,719 1.000% |
31,719 (New Position) |
Filing |